QUOTE AND NEWS
Stock Blog Hub  Aug 25  Comment 
On Friday, Avigen Inc. (AVGN) announced that it will be purchased by MediciNova, Inc. (MNOV) for $1.24 per share in either cash or secured convertible notes. The deal has been valued at about $37 million. Approximately $1.19 of the...
MarketWatch  Aug 21  Comment 
MarketWatch's daily rundown of major gainers and decliners in the stock market.
MarketWatch  Aug 21  Comment 
U.S. stock futures advanced on Friday ahead of data on existing-home sales and a speech from Federal Reserve Chairman Ben Bernanke.
FierceBiotech  Aug 21  Comment 
MediciNova said today that it has finally worked out a deal to buy competing company Avigen for $37 million, or $1.24 per share. The deal represents a 7 percent discount tor Avigen's closing stock price on August 5. Under the terms of the...
FierceBiotech  Jun 26  Comment 
After months of wrangling, MediciNova is close to completing a deal to acquire Avigen. The two companies have reached an "understanding" that values Alameda, CA-based Avigen at its liquidation price plus $3 million. And shareholders would have the...
MarketWatch  Jun 25  Comment 
Biopharmas MediciNova and Avigen said they have reached an understanding on a deal under which Avigen shareholders receive consideration approximating Avigen's net cash liquidation value plus $3 million. Avigen shareholders would be able to...
New York Times  Mar 30  Comment 
Score one for the biotech liquidators. Avigen, a biotechnology company, is preparing to liquidate itself and return its remaining cash to shareholders. The company was pressed to do so by its largest holder, the Biotechnology Value Fund, The New...
New York Times  Mar 28  Comment 
Avigen is one of several biotech businesses that have been under pressure from investors to liquidate after a setback.
Suggest a News Source
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
Close 
Thanks for your suggestion!
 


 
AVGN AT A GLANCE
 
 
 
 
 
 
 
 




References

Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki